Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
As of 2024, over 2% of Americans use GLP-1s for overweight/obesity, and around 4% use them overall (for any indication), with nearly half of users using them for weight loss
Whether you choose to apply it topically or incorporate it into your diet through natural sources or supplements, the benefits are undeniable
Continue avoiding alcohol, caffeine, and smoking for at least 24-48 hours post-treatment
Tirzepatide (Mounjaro) : A dual agonist of GLP-1 and GIP receptors, with studies indicating up to 26.6% weight loss over 84 weeks
The drug itself doesn't interact with contraceptive hormones
The right endpoint is ultimately determined by your provider based on your individual goals
US$ 29.54
US$ 24.81
US$ 29.35
US$ 27.06
US$ 25.83
